Avesthagen and Apollo AyurVAID, a unit of Kerala First Health Services, an Apollo Hospitals Group Company, announced their partnership to design, validate, manufacture, and market a range of scientifically validated medical foods and dietary supplements.
The products to be marketed under the joint brand “AvestaAyurVAID” aim to address specific dietary management of a specific disease or syndrome or disease state for which distinctive nutritional requirements have been established by systematic medical evaluation.
Natural bioactives based on promising Ayurveda botanical candidates shall be developed and validated through Avesthagen’s ADePt, a proprietary bioactive discovery engine, and MetaGrid, an exclusive bioactive testing methodology. The collaboration shall emphasise rigorous scientific and clinical validation to ensure industry-leading product safety and efficacy profile.
Avesthagen and Apollo AyurVAID will design, manufacture and market precision medical foods utilising innovative strategies that enhance patient care, promote holistic wellness, and advance the field of integrative medicine and modern medical nutrition.
Key areas of focus include managing chronic diseases such as diabetes, weight regulation, cardiovascular conditions, and metabolic disorders. Additionally, the partnership shall address onco-nutrition, immunity, cognitive health and mental well-being, ensuring a comprehensive approach to modern medical nutrition.
Avesthagen subsidiaries, Avesta Nordic Research, and Avesta Good Earth Foods will be responsible for the manufacture of products, and Apollo AyurVAID will be responsible for the marketing of products under this agreement. Product development will be a joint responsibility.